Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 08 Dec 2020

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist

in Respiratory Pharmacology

Hélène Salvator
Amparo Buenestado
Marion Brollo
Emmanuel Naline
Tatiana Victoni
Elisabeth Longchamp
Hermann Tenor
Stanislas Grassin-Delyle
Philippe Devillier

Frontiers in Pharmacology

doi 10.3389/fphar.2020.598702

3,415 views
5 citations

Hypothesis and Theory

Published on 26 Nov 2020

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities

in Respiratory Pharmacology

Jonathan D. Geiger
Nabab Khan
Madhuvika Murugan
Detlev Boison

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594487

8,352 views
28 citations

Original Research

Published on 26 Nov 2020

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

in Respiratory Pharmacology

Yukari Satsuma
Hiroaki Ikesue
Kaori Kusuda
Mami Maeda
Nobuyuki Muroi
Ryobu Mori
Mariko Kogo
Ryosuke Hirabayashi
Kazuma Nagata
Atsushi Nakagawa

Frontiers in Pharmacology

doi 10.3389/fphar.2020.529654

3,198 views
8 citations

Original Research

Published on 10 Nov 2020

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

in Respiratory Pharmacology

Fatih M. Uckun
James Carlson
Cemal Orhan
Joy Powell
Natalie M. Pizzimenti
Hendrik van Wyk
Ibrahim H. Ozercan
Michael Volk
Kazim Sahin

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594321

10,556 views
20 citations

Review

Published on 28 Oct 2020

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

in Respiratory Pharmacology

Hongwei Peng
Zhangren Chen
Yunyun Wang
Simei Ren
Tiantian Xu
Xin Lai
Jinhua Wen
Mengjun Zhao
Chuanfei Zeng
Lijuan Du

Frontiers in Pharmacology

doi 10.3389/fphar.2020.554172

6,159 views
8 citations

Original Research

Published on 22 Oct 2020

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

in Respiratory Pharmacology

Jizhen Huang
Xiang Tong
Li Zhang
Yuan Zhang
Lei Wang
Dongguang Wang
Shijie Zhang
Hong Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.550955

7,017 views
43 citations

Hypothesis and Theory

Published on 15 Oct 2020

Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients

in Respiratory Pharmacology

Fuxun Yang
Ruiming Yue
Xiaoxiu Luo
Rongan Liu
Xiaobo Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.543718

39,019 views
24 citations

Perspective

Published on 07 Oct 2020

Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

in Respiratory Pharmacology

Piero Sestili
Carmela Fimognari

Frontiers in Pharmacology

doi 10.3389/fphar.2020.579944

84,878 views
44 citations

Review

Published on 07 Oct 2020

COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence

in Respiratory Pharmacology

Hana Abdelzaher
Basma M. Saleh
Hebatalla A. Ismail
Marwa Hafiz
Macy Abou Gabal
Miranda Mahmoud
Sarah Hashish
Rana M. Abdel Gawad
Rami Y. Gharieb
Anwar Abdelnaser

Frontiers in Pharmacology

doi 10.3389/fphar.2020.579415

17,937 views
19 citations

Case Report

Published on 30 Sep 2020

Dual Monoclonal Antibody Therapy for a Severe Asthma Patient

in Respiratory Pharmacology

Christian Domingo
Xavier Pomares
Anisi Morón
Ana Sogo

Frontiers in Pharmacology

doi 10.3389/fphar.2020.587621

5,100 views
19 citations

Original Research

Published on 25 Sep 2020

Mycobacterium tuberculosis–Specific Antigen Rv3619c Effectively Alleviates Allergic Asthma in Mice

in Respiratory Pharmacology

Hussain A. Safar
Ahmed Z. El-Hashim
Hanady Amoudy
Abu Salim Mustafa

Frontiers in Pharmacology

doi 10.3389/fphar.2020.532199

3,463 views
6 citations

Original Research

Published on 23 Sep 2020

Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells

in Respiratory Pharmacology

Qi Li
Qingsen Ran
Lidong Sun
Jie Yin
Ting Luo
Li Liu
Zheng Zhao
Qing Yang
Yujie Li
Ying Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.522729

41,579 views
17 citations

Original Research

Published on 09 Sep 2020

Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis

in Respiratory Pharmacology

Krishna P. Maremanda
Isaac K. Sundar
Dongmei Li
Irfan Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2020.584637

17,032 views
53 citations

Original Research

Published on 04 Sep 2020

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model

in Respiratory Pharmacology

Shunbo Shi
Lu Xue
Shuhui Han
Haiting Qiu
Yongbo Peng
Ping Zhao
Qing-Hua Liu
Jinhua Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.560361

3,502 views
6 citations

Review

Published on 27 Aug 2020

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019

in Respiratory Pharmacology

Chunsheng Zhu
Bao Sun
Xiaochuan Zhang
Bing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01327

8,341 views
4 citations

Original Research

Published on 19 Aug 2020

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study

in Respiratory Pharmacology

Anushi E. Rajapaksa
Lien Anh Ha Do
Darren Suryawijaya Ong
Magdy Sourial
Duncan Veysey
Richard Beare
William Hughes
William Yang
Robert J. Bischof
Amarin McDonnell

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01291

3,867 views
9 citations

Navigation group

Articles

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients

Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence

Dual Monoclonal Antibody Therapy for a Severe Asthma Patient

Mycobacterium tuberculosis–Specific Antigen Rv3619c Effectively Alleviates Allergic Asthma in Mice

Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells

Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study